RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 27 Dec 2024
Last Applicant/ Owned by
Kloosterstraat 9
Amsterdam
NL
5349ABOS
Serial Number
98451969 filed on 15th Mar 2024
Registration Number
N/A
Correspondent Address
Erica R. Halstead
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
FLINDR THERAPEUTICS
Pharmaceutical drug discovery and development services; scientific services and research, development and design relating thereto in the field of oncology; medical research; technological services, research and design relating thereto in the fields of small molecule therapeutics; design and development of medical technology; design and development of medical diagnostic apparatus; consultancy servi Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug discovery and development services; scientific services and research, development and design relating thereto in the field of oncology; medical research; technological services, research and design relating thereto in the fields of small molecule therapeutics; design and development of medical technology; design and development of medical diagnostic apparatus; consultancy services in the field of technological development of small molecule therapeutics; industrial analysis and industrial research services in the fields of small molecule therapeutics; design and development of computer hardware and software; design and development of small molecule therapeutics hardware and software; clinical research in the fields of small molecule therapeutics; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, hematology and infectious disease; Medical and scientific research, namely, conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; scientific screening and assaying of therapeutics for medical purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology; consultancy services relating to research and development in the field of therapeutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals, medical and veterinary preparations for use in oncology; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceuticals for use in oncology
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; therapeutic tissue, namely, therapeutic tissue comprising or derived from stem cells or progenitor cells, and compositions comprising or derived from the therapeutic tissues for scientific, laboratory, clinical and medical research
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98451969
Mark Type
No Service Mark
Attorney Docket Number
No 115948.00421
44D Filed
Yes
44D Current
Yes
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Dec 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 27th Dec 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 27th Dec 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 07th Oct 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 07th Oct 2024 | NON-FINAL ACTION WRITTEN |
| 07th Oct 2024 | NON-FINAL ACTION E-MAILED |
| 25th Sep 2024 | ASSIGNED TO EXAMINER |
| 09th Aug 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 17th Jun 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| 17th Mar 2024 | NEW APPLICATION ENTERED |